scholarly journals Transcriptional Regulation of Fatty Acid Biosynthesis in Lactococcus lactis

2012 ◽  
Vol 195 (5) ◽  
pp. 1081-1089 ◽  
Author(s):  
T. H. Eckhardt ◽  
D. Skotnicka ◽  
J. Kok ◽  
O. P. Kuipers
Keyword(s):  
Transcriptional Regulation ◽  
Fatty Acid ◽  
Lactococcus Lactis ◽  
Fatty Acid Biosynthesis ◽  
Acid Biosynthesis

scholarly journals Fatty acid biosynthesis and transcriptional regulation of Stearoyl-CoA Desaturase 1 (SCD1) in buffalo milk

BMC Genetics ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Zhipeng Li ◽  
Suyu Lu ◽  
Kuiqing Cui ◽  
Laiba Shafique ◽  
Saif ur Rehman ◽  
...  
Keyword(s):  
Transcriptional Regulation ◽  
Fatty Acid ◽  
Fatty Acid Biosynthesis ◽  
Buffalo Milk ◽  
Acid Biosynthesis ◽  
Stearoyl Coa Desaturase

scholarly journals Transcriptional regulation of fatty acid biosynthesis in mycobacteria

2013 ◽  
Vol 89 (2) ◽  
pp. 372-387 ◽  
Author(s):  
S. Mondino ◽  
G. Gago ◽  
H. Gramajo
Keyword(s):  
Transcriptional Regulation ◽  
Fatty Acid ◽  
Fatty Acid Biosynthesis ◽  
Acid Biosynthesis

Inhibition of early steps of de novo fatty-acid biosynthesis by different xenobiotica

1991 ◽  
Vol 81 (2) ◽  
pp. 251-255
Author(s):  
Manfred Focke ◽  
Andrea Feld ◽  
Hartmut K. Lichtenthaler
Keyword(s):  
Fatty Acid ◽  
Fatty Acid Biosynthesis ◽  
De Novo ◽  
Acid Biosynthesis

Development of 'S', 'N’ Heterocycles as Antimycobacterials Targeting Fatty Acid Biosynthesis

2019 ◽  
Vol 15 ◽  
Author(s):  
L. K. Dahiwade ◽  
S. R. Rochlani ◽  
P. B. Choudhari ◽  
R. P. Dhavale ◽  
H. N. Moreira
Keyword(s):  
Fatty Acid ◽  
Fatty Acid Biosynthesis ◽  
Antimycobacterial Activity ◽  
Drug Candidate ◽  
Causative Organism ◽  
Present Communication ◽  
Acid Biosynthesis ◽  
Rational Development ◽  
After Cancer ◽  
Drug Resistant Strains

Background: Mycobacterium tuberculosis is a causative organism of tuberculosis, which is most deadly disease after cancer in a current decade. The development of multidrug and broadly drug- resistant strains making the tuberculosis problem more and more critical. In last 40 years, only one molecule is added to the treatment regimen. Generally, drug design and development programs are targeted proteins whose function is known to be essential to the bacterial cell. Objectives: Reported here are the development of 'S', 'N’ heterocycles as antimycobacterials targeting fatty acid biosynthesis. Material and Methods: In the present communication, rational development of anti-mycobacterial agent's targeting fatty acid biosynthesis has been done by integrating the pocket modelling and virtual analysis. Results: The identified potential 33 lead compounds were synthesized, characterized by physicochemical and spectroscopic methods like IR, NMR spectroscopy and further screened for antimycobacterial activity using isoniazid as standard. All the designed compounds have shown profound antimycobacterial activity. Conclusion: In this present communication, we found that 3c, 3f, 3l and 4k molecules had expressive desirable biological activity and specific interactions with fatty acids. Further optimization of these leads is necessary for the development of potential antimycobacterial drug candidate having less side effects.

Sign in / Sign up

Export Citation Format

Share Document